For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Interleukin-8 (IL-8), also known as CXCL8, is a chemokine produced by monocytes/macrophages, epithelial cells, endothelial cells and neutrophils, in response to inflammatory stimuli. IL8 is a potent chemoattractant for neutrophils, basophils, and T-cells, and causes degranulation of neutrophil specific granules and azurophilic granules. In addition, IL8 also has a wide range of other proinflammatory effects. IL8 has been linked to various pathologies, including bovine and ovine pneumonic pasteurellosis, bovine salmonellosis, ovine chronic interstitial lung disease and others. This assay allows the quantification of IL8 in bovine samples and given 100% crossreactivity with ovine IL8, could also be used to detected sheep IL8.
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
|Assay Target Class||Cytokine|
|Experimental Type||In vitro|
|Shipping Condition||Blue Ice|
|Unit Size||500 assay points|
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater assay throughput and sensitivity has evolved. In response, more robust immunoassays have been developed to address some of the limitations of the standard, colorimetric ELISA.
Find out about the most common limitations of traditional ELISAs and how different ELISA alternative technologies address these limitations.